Search

everythinglearnresearchcommunity

for

Search:↓

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Testosterone may influence COVID-19 severity and outcomes.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Organoid technology is advancing and entering commercial use, with applications in disease modeling, drug development, and personalized medicine.

New understanding and treatments for hair loss are improving, but more research is needed.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Having a lot of gray hair and hair loss are linked to more severe COVID-19.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Dutasteride and finasteride affect different cell types differently.

Epipharyngeal Abrasive Therapy helps reduce symptoms in Long COVID patients with chronic epipharyngitis.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

COVID-19 can cause hair loss, but specialists can help treat it.

Women with PCOS are more vulnerable to severe COVID-19 and related health issues.

Social media data can help track and predict COVID-19 symptoms and trends.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Anabolic steroid users may face higher risk of severe COVID-19.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Quinoline alkaloids from Cinchona may help treat cancer, diabetes, fungal infections, and promote hair growth.

Certain Dibenzo derivatives may help treat prostate cancer.